Delveinsight

FEBRUARY 9, 2021

Breyanzi will come with a price tag of USD 410,300 wholesale price, said the company, justifying it after taking into consideration several factors including medical and clinical value, patient value, and societal value. Ukoniq’s approval was backed by Phase 2 UNITY-NHL Trial (NCT02793583). The drug received priority review for the MZL.

FDA Approval 52

FDA Approval Marketing Research Protein 52

The Pharma Data

OCTOBER 21, 2020

Those drugs belong to a class called tyrosine kinase inhibitors (TKIs), and include Gleevec — the first TKI approved, back in 2001 — as well as newer ones like Sprycel and Bosulif. When it came to market in 2014, the price tag for one treatment cycle was $89,000. The chemo-free approach could shorten that.

Drugs 52

Drugs Genetics Trials Research 52

The Pharma Data

OCTOBER 21, 2020

Those drugs belong to a class called tyrosine kinase inhibitors (TKIs), and include Gleevec — the first TKI approved, back in 2001 — as well as newer ones like Sprycel and Bosulif. When it came to market in 2014, the price tag for one treatment cycle was $89,000. The chemo-free approach could shorten that.

Drugs 52

Drugs Genetics Trials Research 52

The Pharma Data

MAY 4, 2021

Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Lorbrena, expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). Abrocitinib (PF-04965842). View source version on businesswire.com : [link].

Vaccination 40

Vaccination Vaccine Production Sales 40